Special Issue: Cell-based Therapeutics
08-09-2024
We announce a call for papers for our upcoming special issue focusing on Cell-Based Therapeutics. This issue aims to showcase the transformative impacts of cell-based therapies on clinical practice and the pharmaceutical industry, featuring innovative treatments like genetically reprogrammed T cells for lymphoid cancers and adipose-derived stem cells for Crohn’s disease.
Editors- Yan Ma, Research Associate, Spatial Navigation and Memory Unit, National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health (NIH), Maryland, USA.
- Dr. Meijie Tian, NIH-funded researcher, Oncogenomic section, Genetics Branch, Center of Cancer Research, National Cancer Institute (NCI).
- Dr. Mohd Hussain Shah, Ophthalmology Department, Ohio State University; current research fellow at National Eye Institute (NEI).
- Targeted Delivery and Biodistribution: How cell-based therapies utilize cellular properties for precise therapeutic delivery.
- Advanced Sense-and-Response Functions: The dynamic capabilities of these therapies to monitor and respond to disease states.
- Sustained Endogenous Drug Delivery: Exploring the persistence and long-term benefits of therapeutic cells in vivo.
- Challenges and Solutions: Addressing the hurdles in adoption and commercialization, including cell source stability, safety, and scalable manufacturing processes.
- Next-Generation Engineering Approaches: We are particularly interested in manuscripts discussing innovative engineering approaches such as genome and epigenome editing, synthetic biology, and biomaterial-mediated immune modulation that enhance therapeutic efficacy and address current limitations.
